Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
OptimizeRx Corp. (OPRX) had Stock-Based Compensation of $4.04M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$20.50M |
|
$-0.70M |
|
$4.82M |
|
$15.69M |
|
$20.59M |
|
$-0.09M |
|
$-1.01M |
|
$-1.10M |
|
$-1.10M |
|
$-0.70M |
|
$-0.70M |
|
$-0.70M |
|
$-0.70M |
|
$-0.09M |
|
$1.25M |
|
18.79M |
|
18.79M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$54.15M |
|
$0.12M |
|
$110.17M |
|
$164.32M |
|
$9.71M |
|
$17.76M |
|
$23.52M |
|
$33.23M |
|
$131.08M |
|
$21.50M |
|
$131.08M |
|
18.83M |
|
| Cash Flow Statement Financials | |
$8.14M |
|
$-0.06M |
|
$-7.37M |
|
$23.36M |
|
$24.10M |
|
$0.73M |
|
|
Stock-Based Compensation |
$4.04M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.58 |
|
-- |
|
-- |
|
0.12 |
|
0.14 |
|
76.51% |
|
-0.43% |
|
-0.43% |
|
-- |
|
-5.35% |
|
-3.43% |
|
$8.09M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
-- |
|
0.76 |
|
119.06 |
|
-0.54% |
|
-3.27% |
|
-0.43% |
|
-0.47% |
|
$6.96 |
|
$0.43 |
|
$0.43 |
|